| 期 |
标题 |
文件 |
| 卷 27, 编号 4 (2021) |
Comparative pharmacokinetics of levofloxacin in the saliva and blood plasma of patients with pneumonia |
(Rus)
|
|
Krasnykh L., Goroshko O., Tsyganko D., Berdnicova N., Krasnyanskaya V., Checha O.
|
| 卷 27, 编号 2 (2021) |
Some aspects of pharmacological support with antidysrhythmic drugs |
(Rus)
|
|
Archipov V., Bolsunovskaya Y.
|
| 卷 27, 编号 3 (2021) |
Vaccine safety for COVID-19 prevention |
(Rus)
|
|
Romanov B., Alpatov S., Bogush N., Borozdenko D., Buyanova N., Ganshina I., Dibirova G., Dmitrieva N., Kalinina E., Kirillova A., Kiseleva N., Kukushkin G., Leonteva T., Maximov M., Markina E., Mileshina S., Tsitsuashvili M., Yurov D.
|
| 卷 26, 编号 6 (2020) |
Information service “Database OF Clinical Trials of Pharmaceutical Products” in rational use of hepatoprotectors in preferential pharmaceutical provision |
(Rus)
|
|
Eliseeva E., Maneeva E., Gribova V., Okun D.
|
| 卷 26, 编号 6 (2020) |
Influence of ABCB1 gene polymorphism on rivaroxaban pharmacokinetics |
(Rus)
|
|
Kazakov R., Rodina T., Melnikov E., Danko A., Muslimova O., Demchenkova E., Checha O., Mazerkina I., Belkov S., Prokofev A.
|
| 卷 26, 编号 6 (2020) |
Clinical application of interferon gamma in comprehensive therapy of patients with coronavirus infection |
(Rus)
|
|
Myasnikov A., Berns S., Ershov F.
|
| 卷 26, 编号 6 (2020) |
Efficiency and safety of direct oral anticoagulants in onco-associated venous thromboembolic complications: meta-analysis |
(Rus)
|
|
Petrov V., Akinchits A., Shatalova O., Gorbatenko V., Gerasimenko A.
|
| 卷 26, 编号 3 (2020) |
Possibility of application of the disk diffusion method for studying the sensitivity of coagulase-negative staphylococcus to ceftaroline |
(Rus)
|
|
Bozhkova S., Gordina E., Shneider O.
|
| 卷 26, 编号 4 (2020) |
Neurochemical study of the mechanism of action of thymus peptides in emotional stress |
(Rus)
|
|
Novoseletskaya A., Kiseleva N.
|
| 卷 26, 编号 4 (2020) |
Study of the pharmacokinetics of levofloxacin when combined with st. John’s wort preparations in healthy volunteers and in patients with lower respiratory tract infection |
(Rus)
|
|
Krasnyk L., Goroshko O., Tsyganko D., Berdnicova N., Krasnyanskaya V., Menshov V.
|
| 卷 26, 编号 2 (2020) |
Use of endogenous cholesterol and its metabolite as markers of cyp450 metabolic activity |
(Rus)
|
|
Smirnov V., Krasnykh L., Vasilenko G., Ramenskaya G., Checha O.
|
| 卷 26, 编号 1 (2020) |
New pharmacological effects of caripazim |
(Rus)
|
|
Kukushkin G., Zhuravleva M., Sviridkina L., Yurov D.
|
| 卷 26, 编号 1 (2020) |
Comparative assessment of tolerability and risk of pharmacotherapy with botulinum toxin type a drugs in children with cerebral palsy with severe spasticity syndrome |
(Rus)
|
|
Arkhipov V., Goryachev D., Chebanenko N., Solovyova A.
|
| 1 - 13 的 13 信息 |
|
